newsletter3

banner-about

suPARnostic® Measures suPAR

suPAR is a novel biomarker test for triage in the emergency departments handling acutely ill patients, where suPAR can act as a master alarm for patients who are at risk of suPARscalenon-survival. The suPARnostic® test can help with triage admission management and monitoring for patient survival. With more than 400 published studies on suPARnostic® it is clearly established that the suPARnostic® level of an individual can be usefully applied as an indicator for patient survival and as a prioritisation tool.

Numerous published research studies show that with a suPARnostic® measurement between 0.1 to 4.0 ng/mL, a patient can be considered healthy, with no challenges to the immune system and no signs or symptoms of an opportunistic infection or inflammation.

At suPARnostic® measurements between 4.0 and 9.0 ng/mL, a patient's immune system can be considered 'negatively activated' (by non-specific challenge), indicating a potential infection or high level of inflammation. In this case, the patient should be referred for further testing, as his/her condition will likely worsen to a possible critical infection or condition.

Finally, suPARnostic® measurements of 9.0 ng/mL to double digit levels can indicate a serious illness that is progressing rapidly to a critical situation. Patients with suPARnostic® levels above 15 ng/mL might generally be too sick to present themselves to clinics by their own strength. At this level the risk of mortality is very high.

 

Contact us

virogates logo2
Blokken 45

3460 Birkerød
Denmark

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033
E-mail: info@virogates.com

 in-2  tw-2